WallStSmart

ALT5 Sigma Corporation (ALTS)vsSalesforce.com Inc (CRM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Salesforce.com Inc generates 186487% more annual revenue ($41.52B vs $22.25M). CRM leads profitability with a 18.0% profit margin vs -74.9%. ALTS appears more attractively valued with a PEG of 0.97. CRM earns a higher WallStSmart Score of 63/100 (C+).

ALTS

Buy

54

out of 100

Grade: C-

Growth: 5.3Profit: 2.0Value: 6.7Quality: 5.0

CRM

Buy

63

out of 100

Grade: C+

Growth: 6.7Profit: 7.0Value: 10.0Quality: 6.0
Piotroski: 5/9Altman Z: 1.83
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for ALTS.

CRMUndervalued (+34.2%)

Margin of Safety

+34.2%

Fair Value

$276.43

Current Price

$181.96

$94.47 discount

UndervaluedFair: $276.43Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ALTS2 strengths · Avg: 9.0/10
EPS GrowthGrowth
118.7%10/10

Earnings expanding 118.7% YoY

PEG RatioValuation
0.978/10

Growing faster than its price suggests

CRM4 strengths · Avg: 8.5/10
Market CapQuality
$171.49B9/10

Large-cap with strong market position

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$5.32B8/10

Generating 5.3B in free cash flow

Areas to Watch

ALTS4 concerns · Avg: 2.8/10
Revenue GrowthGrowth
1.9%4/10

1.9% revenue growth

Market CapQuality
$238.65M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-44.8%2/10

ROE of -44.8% — below average capital efficiency

Free Cash FlowQuality
$-8.76M2/10

Negative free cash flow — burning cash

CRM1 concerns · Avg: 4.0/10
Altman Z-ScoreHealth
1.834/10

Grey zone — moderate risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ALTS

The strongest argument for ALTS centers on EPS Growth, PEG Ratio. PEG of 0.97 suggests the stock is reasonably priced for its growth.

Bull Case : CRM

The strongest argument for CRM centers on Market Cap, Debt/Equity, Price/Book. Profitability is solid with margins at 18.0% and operating margin at 19.2%. Revenue growth of 12.1% demonstrates continued momentum.

Bear Case : ALTS

The primary concerns for ALTS are Revenue Growth, Market Cap, Return on Equity.

Bear Case : CRM

The primary concerns for CRM are Altman Z-Score.

Key Dynamics to Monitor

ALTS profiles as a turnaround stock while CRM is a mature play — different risk/reward profiles.

ALTS carries more volatility with a beta of 1.60 — expect wider price swings.

CRM is growing revenue faster at 12.1% — sustainability is the question.

CRM generates stronger free cash flow (5.3B), providing more financial flexibility.

Bottom Line

CRM scores higher overall (63/100 vs 54/100), backed by strong 18.0% margins and 12.1% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

ALT5 Sigma Corporation

TECHNOLOGY · SOFTWARE - APPLICATION · USA

ALT5 Sigma Corporation operates a next generation blockchain platform. The company is headquartered in Las Vegas, Nevada.

Salesforce.com Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Salesforce.com, Inc. is an American cloud-based software company headquartered in San Francisco, California. It provides customer relationship management (CRM) service and also provides a complementary suite of enterprise applications focused on customer service, marketing automation, analytics, and application development.

Visit Website →

Want to dig deeper into these stocks?